Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 20
214
Views
3
CrossRef citations to date
0
Altmetric
SHORT COMMUNICATION

A new chemotype with high tricyclene content from the essential oil of Salvia aegyptiaca L. growing in Algerian Pre-Sahara

, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 5364-5369 | Received 29 Dec 2020, Accepted 06 May 2021, Published online: 27 May 2021
 

Abstract

The essential oil obtained by hydrodistillation from the aerial parts of Salvia aegyptiaca L. (Lamiaceae) growing wild in pre-Saharan region of Algeria, was analysed by GC-MS. Forty-one compounds were detected, representing 87.9% of the whole oil. The essential oil of S. aegyptiaca is characterized by the predominance of monoterpene derivatives (70.6%). The major constituents were tricyclene (22.9%), followed by limonene (17.5%), β-pinene (7.4%), caryophyllene oxide (3.2%) and β-caryophyllene (3.1%). Tricyclene, the main component in our analysis is generally absent in the volatile oils from other Salvia species, therefore, the Algerian accession of S. aegyptiaca may be categorized as a new chemo-type.

Acknowledgments

The authors are grateful to the financial support of the Ministry of Higher Education and Scientific Research, Algeria. We are grateful the thank Dr. Petulia Blake for collaboration.

Disclosure statement

No potential conflict of interest was reported by the authors.

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.